{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:56:28Z","timestamp":1792652188701,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neurobiolaging.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T11:45:38Z","timestamp":1610624738000},"page":"94-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Bacille Calmette-Gu\u00e9rin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP\/PS1 mice following active amyloid-\u03b2 immunotherapy"],"prefix":"10.1016","volume":"101","author":[{"given":"Zejie","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9616-1663","authenticated-orcid":false,"given":"Yunjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib1","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A\u00a0dural lymphatic vascular system that drains brain interstitial fluid and macromolecules","volume":"212","author":"Aspelund","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib2","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1038\/cddis.2013.325","article-title":"Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis","volume":"4","author":"Azevedo","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/14712598.2019.1554646","article-title":"A\u00a0vaccine against Alzheimer\u2019s disease: anything left but faith?","volume":"19","author":"Bachmann","year":"2019","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/brain\/awv313","article-title":"Passive immunotherapy targeting amyloid-\u03b2 reduces cerebral amyloid angiopathy and improves vascular reactivity","volume":"139","author":"Bales","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm.4022","article-title":"PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease","volume":"22","author":"Baruch","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12471-017-0959-2","article-title":"Pathophysiology and treatment of atherosclerosis","volume":"25","author":"Bergheanu","year":"2017","journal-title":"Neth. Heart J."},{"issue":"Pt 12","key":"10.1016\/j.neurobiolaging.2021.01.001_bib7","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awn261","article-title":"Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain","volume":"131","author":"Boche","year":"2008","journal-title":"Brain."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib9","doi-asserted-by":"crossref","first-page":"30459","DOI":"10.1038\/srep30459","article-title":"IL-10 promotes neurite outgrowth and synapse formation in cultured cortical neurons after the oxygen-glucose deprivation via JAK1\/STAT3 pathway","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib10","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1073\/pnas.0807991106","article-title":"Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib11","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.5489\/cuaj.4759","article-title":"Case: Bacillus Calmette-Guerin (BCG)-induced Reiter syndrome with an attempt at repeat BCG induction","volume":"12","author":"Cheung","year":"2018","journal-title":"Can. Urol. Assoc. J."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.20171484","article-title":"Combination anti-A\u03b2 treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice","volume":"215","author":"Chiang","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib13","doi-asserted-by":"crossref","first-page":"17913","DOI":"10.1073\/pnas.0804610105","article-title":"T\u00a0lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib14","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1073\/pnas.0913449107","article-title":"Enhanced synaptic connectivity and epilepsy in C1q knockout mice","volume":"107","author":"Chu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/cts.12491","article-title":"Lessons learned from Alzheimer disease: clinical trials with negative outcomes","volume":"11","author":"Cummings","year":"2018","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","article-title":"Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease","volume":"560","author":"Da Mesquita","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2016.09.007","article-title":"Abeta vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Abeta, and microhemorrhages","volume":"49","author":"Davis","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib18","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1471-4159.2010.07058.x","article-title":"N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-beta peptide oligomers","volume":"115","author":"Decker","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib19","doi-asserted-by":"crossref","first-page":"e41756","DOI":"10.1371\/journal.pone.0041756","article-title":"Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes","volume":"7","author":"Faustman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.coi.2004.08.002","article-title":"Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates","volume":"16","author":"Gandy","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/imm.12279","article-title":"Molecular mechanisms regulating CD13-mediated adhesion","volume":"142","author":"Ghosh","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib22","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib23","doi-asserted-by":"crossref","first-page":"e0224433","DOI":"10.1371\/journal.pone.0224433","article-title":"Bacillus Calmette-Guerin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients","volume":"14","author":"Gofrit","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib24","doi-asserted-by":"crossref","first-page":"e2005264","DOI":"10.1371\/journal.pbio.2005264","article-title":"Peripherally derived macrophages modulate microglial function to reduce inflammation after CNS injury","volume":"16","author":"Greenhalgh","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib25","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4161\/hv.24830","article-title":"Immunotherapeutic efficiency of a tetravalent Abeta1-15 vaccine in APP\/PS1 transgenic mice as mouse model for Alzheimer's disease","volume":"9","author":"Guan","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","article-title":"Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology","volume":"85","author":"Guillot-Sestier","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1073\/pnas.0805453106","article-title":"Selective targeting of perivascular macrophages for clearance of \u03b2-amyloid in cerebral amyloid angiopathy","volume":"106","author":"Hawkes","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib29","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41467-018-08163-0","article-title":"Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells","volume":"10","author":"Hsu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/jgs.15830","article-title":"Major clinical trials failed the amyloid hypothesis of Alzheimer's disease","volume":"67","author":"Huang","year":"2019","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib33","doi-asserted-by":"crossref","first-page":"e01586","DOI":"10.1128\/mBio.01586-16","article-title":"Origins of combination therapy for tuberculosis: lessons for future antimicrobial development and application","volume":"8","author":"Kerantzas","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib34","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A\u00a0unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib35","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/brain\/awv150","article-title":"Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer\u2019s disease","volume":"138","author":"Koronyo","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"A\u03b2 oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"Lambrecht","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1326-8-36","article-title":"Immunotherapy for Alzheimer's disease: hoops and hurdles","volume":"8","author":"Lemere","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib39","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","article-title":"Soluble Abeta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors","volume":"31","author":"Li","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib40","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib41","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1172\/JCI23874","article-title":"Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages","volume":"115","author":"Maruyama","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/diab.40.6.715","article-title":"Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice","volume":"40","author":"McInerney","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.celrep.2013.10.010","article-title":"Real-time in\u00a0vivo imaging reveals the ability of monocytes to clear vascular amyloid beta","volume":"5","author":"Michaud","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","article-title":"High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease","volume":"48","author":"Mrdjen","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib45","doi-asserted-by":"crossref","first-page":"101851","DOI":"10.1016\/j.tube.2019.07.002","article-title":"A\u00a0standardized BioBrick toolbox for the assembly of sequences in mycobacteria","volume":"119","author":"Oliveira","year":"2019","journal-title":"Tuberculosis"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib46","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","article-title":"Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients - a biochemical analysis","volume":"169","author":"Patton","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib47","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.1078259","article-title":"Cerebral hemorrhage after passive anti-Abeta immunotherapy","volume":"298","author":"Pfeifer","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000113700","article-title":"Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis","volume":"5","author":"Pride","year":"2008","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","article-title":"Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid \u03b2","volume":"25","author":"Racke","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib50","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mdy089","article-title":"Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients","volume":"29","author":"Rodr\u00edguez-Ruiz","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib51","series-title":"The Value of BCG and TNF in Autoimmunity","first-page":"25","article-title":"Chapter 3 - Bacille Calmette-Gu\u00e9rin (BCG) vaccine in neuroinflammation","author":"Romano","year":"2018"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib52","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2018.00029","article-title":"Adjuvant effect of Bacille Calmette\u2013Gu\u00e9rin on hepatitis b vaccine immunogenicity in the preterm and term newborn","volume":"9","author":"Scheid","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib55","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1523\/JNEUROSCI.2377-07.2008","article-title":"Immunotherapy reduces vascular amyloid-\u03b2 in PDAPP mice","volume":"28","author":"Schroeter","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib56","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tips.2008.03.006","article-title":"Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease?","volume":"29","author":"Schwartz","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib57","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.180.8.5402","article-title":"The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells","volume":"180","author":"Seubert","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces Abeta plaques in Alzheimer's disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib59","doi-asserted-by":"crossref","first-page":"eaaf6295","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice","volume":"9","author":"Shi","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib60","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","article-title":"Vascular contributions to cognitive impairment and dementia including Alzheimer's disease","volume":"11","author":"Snyder","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib62","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1073\/pnas.0813404106","article-title":"Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice","volume":"106","author":"Thakker","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3940(00)01767-5","article-title":"Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice","volume":"299","author":"Tomidokoro","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib64","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","article-title":"Innate immune memory in the brain shapes neurological disease hallmarks","volume":"556","author":"Wendeln","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib65","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib66","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1523\/JNEUROSCI.0293-11.2011","article-title":"The second-generation active Abeta immunotherapy CAD106 reduces amyloid accumulation in APP transgenic mice while minimizing potential side effects","volume":"31","author":"Wiessner","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib67","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuroscience.2006.10.020","article-title":"Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid","volume":"144","author":"Wilcock","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-1-24","article-title":"Passive immunotherapy against A beta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage","volume":"1","author":"Wilcock","year":"2004","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt237","article-title":"Active immunotherapy options for Alzheimer's disease","volume":"6","author":"Winblad","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib70","doi-asserted-by":"crossref","first-page":"e16610","DOI":"10.1371\/journal.pone.0016610","article-title":"BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease","volume":"6","author":"Yong","year":"2011","journal-title":"PLoS One"},{"issue":"5 Suppl","key":"10.1016\/j.neurobiolaging.2021.01.001_bib71","first-page":"S105","article-title":"Vascular alterations in PDAPP mice after anti-Abeta immunotherapy: implications for amyloid-related imaging abnormalities","volume":"9","author":"Zago","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib72","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1080\/21645515.2015.1034922","article-title":"Continuous vaccinations of 4Abeta1-15 induces specific fluctuation of inflammatory factors accompany with pathologic alterations alleviation in APP\/PS1 mice","volume":"11","author":"Zhang","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib73","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nn1629","article-title":"Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood","volume":"9","author":"Ziv","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt 9","key":"10.1016\/j.neurobiolaging.2021.01.001_bib75","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer's disease and after active amyloid-beta42 immunization","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain."},{"key":"10.1016\/j.neurobiolaging.2021.01.001_bib76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2017.02.001","article-title":"Immunization with Bacillus Calmette-Gu\u00e9rin (BCG) alleviates neuroinflammation and cognitive deficits in APP\/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain","volume":"101","author":"Zuo","year":"2017","journal-title":"Neurobiol. Dis."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:36:19Z","timestamp":1759318579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021000014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":76,"alternative-id":["S0197458021000014"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.001","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacille Calmette-Gu\u00e9rin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP\/PS1 mice following active amyloid-\u03b2 immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}